| Other expenses and adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the years ended December 31, |
2021 |
|
2020 |
|
2019 |
| Included in research and development expenses: |
|
|
|
|
|
| Employee compensation and benefits |
$ |
4,645,264
|
|
|
$ |
3,775,263 |
|
|
$ |
3,096,231 |
|
| Share-based compensation |
2,086,608
|
|
|
1,043,373 |
|
|
561,420 |
|
|
|
|
|
|
|
| Included in operating expenses |
|
|
|
|
|
| Depreciation - property and equipment |
$ |
130,243
|
|
|
$ |
88,957 |
|
|
$ |
122,982 |
|
| Depreciation - right-of-use assets |
321,822
|
|
|
357,230 |
|
|
362,592 |
|
| Employee compensation and benefits |
2,542,210
|
|
|
2,635,170 |
|
|
2,555,274 |
|
| Share-based compensation |
1,739,293
|
|
|
1,515,601 |
|
|
908,733 |
|
| Transaction cost, warrant derivative |
—
|
|
|
— |
|
|
233,143 |
|
|